摘要:
PCT No. PCT/US92/03317 Sec. 371 Date May 23, 1994 Sec. 102(e) Date May 23, 1994 PCT Filed Apr. 28, 1992 PCT Pub. No. WO92/21677 PCT Pub. Date Dec. 10, 1992Compounds of the formula I wherein R1 is methoxy and R2 is selected from the group consisting of methyl, ethyl, isopropyl, sec-butyl and tert-butyl; and the pharmaceutically acceptable salts of such compounds. These compounds are substance P antagonists and useful in the treatment of gastrointestinal disorders, inflammatory disorders, central nervous system disorders and pain.
摘要:
PCT No. PCT/US92/03317 Sec. 371 Date May 23, 1994 Sec. 102(e) Date May 23, 1994 PCT Filed Apr. 28, 1992 PCT Pub. No. WO92/21677 PCT Pub. Date Dec. 10, 1992Compounds of the formula I wherein R1 is methoxy and R2 is selected from the group consisting of methyl, ethyl, isopropyl, sec-butyl and tert-butyl; and the pharmaceutically acceptable salts of such compounds. These compounds are substance P antagonists and useful in the treatment of gastrointestinal disorders, inflammatory disorders, central nervous system disorders and pain.
摘要:
PURPOSE:To obtain the objective compound in high yield and readily in production of a cyano compound useful as a raw material especially for medicines, agricultural chemicals and liquid crystal substance by cyanating a nucleophilic reaction accepting compound with a trisubstituted silylanilide by using a specific catalyst. CONSTITUTION:In cyanating a nucleophilic reaction accepting compound such as carbonyl compound, e.g. aldehyde or ketone, imine compound or nitroolefin compound, preferably aldehyde with a trisubstituted silylanilide, a Lewis base such as organic amine compound, organic phosphorus compound, organic arsenic compound or organic antimony compound, preferably cinchonine or a derivative thereof, especially a cinchonine derivative shown by the formula (Tb is trifluoromethanesulfonic acid residue) as an asymmetric synthetic catalyst to improve yield, especially optical yield of the objective compound. The catalyst for asymmetric synthesis is readily obtainable and more stably and inexpensively supplied than existing catalysts for asymmetric synthesis.
摘要:
NEW MATERIAL:The compound of formula I [R to R are H, alkyl, phenyl, heteroaryl, etc.; R is H, alkyl, alkanoyl, etc.; R to R are H, halogen, alkyl, etc.; X is O or S; Y is O or N-R (R is H or alkyl); R is group of formula II (m is 0 or 1; n is 0-2), etc.], its geometrical isomer, optical isomer and salt. EXAMPLE:6-Chloro-4-methyl-N-(3-quinuclidinyl)-3,4-dihydro-2H-1,4-benzo xazine-8- carboxamide. USE:The compound exhibits antagonistic action against 5-HT3 receptor and is useful for the remedy of diseases of neutral nervous system and gastrointestinal diseases. PREPARATION:The compound of formula I can be produced by reacting a compound of formula III or its reactive derivative with a compound of formula R -YH in the presence of a condensation agent (e.g. dicyclohexylcarbodiimide) in an inert solvent under cooling, at room temperature or under heating.
摘要:
The microorganism Streptomyces cattleya, preferably the strain NRRL 8057, is cultivated under submerged aerobic conditions in an aqueous nutrient medium containing assimilable C and N sources as well as inorganic salts. N-Acetylthienamycin is obtained. Non-toxic, pharmaceutically acceptable salts of N-acetylthienamycin can be obtained by reaction with inorganic or organic bases. N-acetylthienamycin and its salts show remarkable antibiotic properties and are active against a wide range of pathogens as well as against resistant strains of particular microorganisms. The antibiotic is active against Gram-positive and -negative bacteria and is suitable for use in human and veterinary medicine and as antibacterial agent for commercial and industrial purposes.